关于亨廷顿病的症状管理的基于证据的审查
Jung Hwan Shin1, Hui-Jun Yang2, Jong Hyun Ahn3
1Department of Neurology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
Journal of movement disorders
|August 8, 2024
概括
本综述系统地检查了针对亨廷顿病的干预措施.
科学领域:
- 神经科学和神经病学 神经科学和神经病学
- 临床医学 临床医学
背景情况:
- 亨廷顿病 (HD) 是一种进展性神经退行性疾病,影响运动,认知和行为功能.
- 疾病严重降低了患者的生活质量,需要有效的症状管理策略.
研究的目的:
- 系统地审查当前用于管理23种亨廷顿病症状的药理和非药理干预措施.
- 为HD的症状治疗提供基于证据的摘要.
主要方法:
- 按照PRISMA指南进行系统的文献搜索,涵盖到2022年8月的研究.
- 分析的重点是针对运动,神经心理,认知和其他HD症状领域的干预措施.
主要成果:
- 确定并审查了针对广泛的亨廷顿病症状的现有干预措施.
- 强调了各种管理方法的现有证据.
结论:
- 介绍了亨廷顿病的症状管理的全面概述.
- 强调需要更多高质量的临床试验,以建立强有力的,基于证据的HD护理指南.
相关概念视频
Parkinson's Disease: Treatment
241
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
241
Parkinson's Disease: Overview
508
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
508
Alzheimer's Disease: Treatment
171
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
171
Mania and Antimanic Drugs: Overview
155
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Neural Regulation
39.2K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.2K


